Paradigm Biocapital Advisors’s Nuvalent NUVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$545M	Buy	5,324,433 +55,000	+1%	+$5.61M	11.15%	3
2025 Q4	$530M	Hold	5,269,433	–	–	14.19%	1
2025 Q3	$456M	Hold	5,269,433	–	–	13.48%	1
2025 Q2	$402M	Hold	5,269,433	–	–	17.17%	1
2025 Q1	$374M	Sell	5,269,433 -93,946	-2%	-$7.35M	17.2%	1
2024 Q4	$420M	Buy	5,363,379 +363,379	+7%	+$33.9M	14.61%	1
2024 Q3	$512M	Buy	5,000,000 +428,322	+9%	+$35.5M	17.9%	1
2024 Q2	$347M	Buy	4,571,678 +393,848	+9%	+$28M	13.27%	1
2024 Q1	$314M	Buy	4,177,830 +319,822	+8%	+$25.5M	11.04%	1
2023 Q4	$284M	Buy	3,858,008 +2,219,861	+136%	+$137M	13.31%	1
2023 Q3	$75.3M	Buy	1,638,147 +517,682	+46%	+$23M	5.14%	5
2023 Q2	$47.3M	Buy	+1,120,465	New	+$42.4M	3.82%	14